PainChek LtdASX: PCK

Trading Halt

· Issued by PainChek Ltd

Filed with ASX · · 3 pages · English

Summary by 6ix AI

PainChek Ltd has requested a trading halt from the Australian Securities Exchange pending an announcement regarding regulatory clearance from the U.S. Food and Drug Administration. The halt will remain in effect until the earlier of the announcement or the commencement of normal trading on a specified date. This request has been approved by the Company's Board of Directors and aims to prevent uninformed trading in its securities.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

PainChek Ltd on 6ix

Earlier from PainChek

Later from PainChek

All PainChek news releases